Perspective Net Tangible Assets from 2010 to 2026
| CATX Stock | 4.85 0.15 3.19% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 70.3 M | Current Value 49.1 M | Quarterly Volatility 28.7 M |
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 0.0 or Gross Profit of 1.2 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 0.6. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
Perspective | Net Tangible Assets | Build AI portfolio with Perspective Stock |
The evolution of Net Tangible Assets for Perspective Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Perspective Therapeutics compares to historical norms and industry peers.
Latest Perspective Therapeutics' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Perspective Therapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Perspective Therapeutics' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Perspective Net Tangible Assets Regression Statistics
| Arithmetic Mean | 28,664,482 | |
| Geometric Mean | 14,978,495 | |
| Coefficient Of Variation | 100.21 | |
| Mean Deviation | 27,152,332 | |
| Median | 5,585,000 | |
| Standard Deviation | 28,723,527 | |
| Sample Variance | 825T | |
| Range | 64.8M | |
| R-Value | 0.83 | |
| Mean Square Error | 274.1T | |
| R-Squared | 0.69 | |
| Significance | 0.000038 | |
| Slope | 4,719,885 | |
| Total Sum of Squares | 13200.7T |
Perspective Net Tangible Assets History
About Perspective Therapeutics Financial Statements
Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Net Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 70.3 M | 49.1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Perspective Stock Analysis
When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.